Skip to content
The Longevity Archive
KLOW blend in all countries

Legal status · United Kingdom

Is KLOW blend legal in the United Kingdom?

Not approvedHealing & RecoveryEvidence: Preliminary

No. KLOW blend is not an approved medicine in the United Kingdom; its classification is "Unlicensed medicine; supply for human use is unlawful". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.

KLOW blend in the United Kingdom at a glance

ClassificationUnlicensed medicine; supply for human use is unlawful
MHRA approval statusNot approved by MHRA
Evidence levelPreliminary (research strength: Preliminary)
ReviewedSep 2026

Classification and note come from the KLOW blend profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    No product containing KLOW blend is approved by MHRA for any use in the United Kingdom, so nothing on the market is authorized for people.

  • 02

    "Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.

  • 03

    Importing, supplying or promoting it for human use can fall under medicines legislation in the United Kingdom. This page is general information, not legal advice.

What KLOW blend is

A four-peptide vendor blend, typically 50 mg GHK-Cu with 10 mg each of KPV, BPC-157 and TB-500, sold for repair and inflammation; no study has ever tested the combination, and GHK-Cu makes up most of the vial.

KLOW is one of the most widely stocked gray-market products of 2026. It bundles the copper peptide GHK-Cu (about 62% of the vial by mass) with the anti-inflammatory tripeptide KPV and the healing peptides BPC-157 and TB-500.

Mechanism: Assumed sum of the parts: copper-peptide collagen and repair signaling (GHK-Cu), MC1R and NF-kB anti-inflammatory effects (KPV), and BPC-157/TB-500 tissue-repair pathways, all from animal or in-vitro work.

Regulatory history: Not approved; unstudied combination

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for KLOW blend at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

KLOW blend in other countries

Frequently asked questions

Is KLOW blend legal in the United Kingdom?

No. KLOW blend is not an approved medicine in the United Kingdom; its classification is "Unlicensed medicine; supply for human use is unlawful". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.

Can I buy KLOW blend in the United Kingdom?

No approved product exists to buy. In the United Kingdom KLOW blend is classified as "Unlicensed medicine; supply for human use is unlawful", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is KLOW blend MHRA approved?

No. In the United Kingdom KLOW blend is classified as "Unlicensed medicine; supply for human use is unlawful", which is not a MHRA marketing approval. For comparison, the US FDA status is: Not approved; unstudied combination. Evidence level: Preliminary.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for KLOW blend live on its compound profile.

KLOW blend profile

This page is general information about the regulatory status of KLOW blend in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.